Global Infectious Disease Point of Care Diagnostics Market Insights, Forecast to 2030

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Over-the-counter (OTC) Testing Kits
1.2.3 Prescription-based Testing Kits
1.3 Market by Application
1.3.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Bacterial Infections
1.3.3 Fungal Infection
1.3.4 Virus Infection
1.3.5 Cardiovascular Infection
1.3.6 Gastrointestinal Infection
1.3.7 Sexually Transmitted Disease (STD) Infection
1.3.8 Central Nervous System Infection
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Point of Care Diagnostics Market Perspective (2019-2030)
2.2 Global Infectious Disease Point of Care Diagnostics Growth Trends by Region
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Point of Care Diagnostics Market Dynamics
2.3.1 Infectious Disease Point of Care Diagnostics Industry Trends
2.3.2 Infectious Disease Point of Care Diagnostics Market Drivers
2.3.3 Infectious Disease Point of Care Diagnostics Market Challenges
2.3.4 Infectious Disease Point of Care Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Infectious Disease Point of Care Diagnostics by Players
3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Infectious Disease Point of Care Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2023
3.5 Global Key Players of Infectious Disease Point of Care Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Disease Point of Care Diagnostics, Product and Application
3.7 Global Key Players of Infectious Disease Point of Care Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Point of Care Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type
6.2.1 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Application
6.3.1 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Country
6.4.1 North America Infectious Disease Point of Care Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type
7.2.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application
7.3.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Country
7.4.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
8.2 China Infectious Disease Point of Care Diagnostics Market Size by Type
8.2.1 China Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024)
8.2.2 China Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030)
8.2.3 China Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
8.3 China Infectious Disease Point of Care Diagnostics Market Size by Application
8.3.1 China Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024)
8.3.2 China Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030)
8.3.3 China Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
9.2 Asia Infectious Disease Point of Care Diagnostics Market Size by Type
9.2.1 Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
9.3 Asia Infectious Disease Point of Care Diagnostics Market Size by Application
9.3.1 Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
9.4 Asia Infectious Disease Point of Care Diagnostics Market Size by Region
9.4.1 Asia Infectious Disease Point of Care Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Infectious Disease Point of Care Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Infectious Disease Point of Care Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
11.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
11.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.2.5 Siemens Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
11.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.3.5 GE Healthcare Recent Developments
11.4 Accriva
11.4.1 Accriva Company Details
11.4.2 Accriva Business Overview
11.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
11.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.4.5 Accriva Recent Developments
11.5 Terumo
11.5.1 Terumo Company Details
11.5.2 Terumo Business Overview
11.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
11.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.5.5 Terumo Recent Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Details
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
11.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.6.5 BioMerieux Recent Developments
11.7 Diasorin
11.7.1 Diasorin Company Details
11.7.2 Diasorin Business Overview
11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
11.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.7.5 Diasorin Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
11.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.8.5 Roche Recent Developments
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Details
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
11.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.9.5 Danaher Corporation Recent Developments
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
11.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.10.5 BD Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 Cavidi
11.12.1 Cavidi Company Details
11.12.2 Cavidi Business Overview
11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
11.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.12.5 Cavidi Recent Developments
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
11.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.13.5 Cepheid Recent Developments
11.14 Diaxonhit
11.14.1 Diaxonhit Company Details
11.14.2 Diaxonhit Business Overview
11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
11.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.14.5 Diaxonhit Recent Developments
11.15 Eiken Chemical
11.15.1 Eiken Chemical Company Details
11.15.2 Eiken Chemical Business Overview
11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
11.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.15.5 Eiken Chemical Recent Developments
11.16 EMD Millipore
11.16.1 EMD Millipore Company Details
11.16.2 EMD Millipore Business Overview
11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
11.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.16.5 EMD Millipore Recent Developments
11.17 Epitope Diagnostic
11.17.1 Epitope Diagnostic Company Details
11.17.2 Epitope Diagnostic Business Overview
11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
11.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.17.5 Epitope Diagnostic Recent Developments
11.18 Euroimmun
11.18.1 Euroimmun Company Details
11.18.2 Euroimmun Business Overview
11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
11.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.18.5 Euroimmun Recent Developments
11.19 Gold Standard Diagnostics
11.19.1 Gold Standard Diagnostics Company Details
11.19.2 Gold Standard Diagnostics Business Overview
11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
11.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.19.5 Gold Standard Diagnostics Recent Developments
11.20 Hologic
11.20.1 Hologic Company Details
11.20.2 Hologic Business Overview
11.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
11.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.20.5 Hologic Recent Developments
11.21 Immunetics
11.21.1 Immunetics Company Details
11.21.2 Immunetics Business Overview
11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
11.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.21.5 Immunetics Recent Developments
11.22 InBios International
11.22.1 InBios International Company Details
11.22.2 InBios International Business Overview
11.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
11.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024)
11.22.5 InBios International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Over-the-counter (OTC) Testing Kits
Table 3. Key Players of Prescription-based Testing Kits
Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2019-2024)
Table 8. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2025-2030)
Table 10. Infectious Disease Point of Care Diagnostics Market Trends
Table 11. Infectious Disease Point of Care Diagnostics Market Drivers
Table 12. Infectious Disease Point of Care Diagnostics Market Challenges
Table 13. Infectious Disease Point of Care Diagnostics Market Restraints
Table 14. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Infectious Disease Point of Care Diagnostics Revenue Share by Players (2019-2024)
Table 16. Global Top Infectious Disease Point of Care Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2023)
Table 17. Global Infectious Disease Point of Care Diagnostics Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Infectious Disease Point of Care Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Infectious Disease Point of Care Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Infectious Disease Point of Care Diagnostics, Product and Application
Table 21. Global Key Players of Infectious Disease Point of Care Diagnostics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Share by Application (2019-2024)
Table 29. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Infectious Disease Point of Care Diagnostics Revenue Share by Application (2025-2030)
Table 31. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Infectious Disease Point of Care Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Infectious Disease Point of Care Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Infectious Disease Point of Care Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Infectious Disease Point of Care Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Infectious Disease Point of Care Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Infectious Disease Point of Care Diagnostics Product
Table 66. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Abbott Recent Developments
Table 68. Siemens Company Details
Table 69. Siemens Business Overview
Table 70. Siemens Infectious Disease Point of Care Diagnostics Product
Table 71. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Siemens Recent Developments
Table 73. GE Healthcare Company Details
Table 74. GE Healthcare Business Overview
Table 75. GE Healthcare Infectious Disease Point of Care Diagnostics Product
Table 76. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 77. GE Healthcare Recent Developments
Table 78. Accriva Company Details
Table 79. Accriva Business Overview
Table 80. Accriva Infectious Disease Point of Care Diagnostics Product
Table 81. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Accriva Recent Developments
Table 83. Terumo Company Details
Table 84. Terumo Business Overview
Table 85. Terumo Infectious Disease Point of Care Diagnostics Product
Table 86. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Terumo Recent Developments
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Infectious Disease Point of Care Diagnostics Product
Table 91. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 92. BioMerieux Recent Developments
Table 93. Diasorin Company Details
Table 94. Diasorin Business Overview
Table 95. Diasorin Infectious Disease Point of Care Diagnostics Product
Table 96. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Diasorin Recent Developments
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Infectious Disease Point of Care Diagnostics Product
Table 101. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 102. Roche Recent Developments
Table 103. Danaher Corporation Company Details
Table 104. Danaher Corporation Business Overview
Table 105. Danaher Corporation Infectious Disease Point of Care Diagnostics Product
Table 106. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 107. Danaher Corporation Recent Developments
Table 108. BD Company Details
Table 109. BD Business Overview
Table 110. BD Infectious Disease Point of Care Diagnostics Product
Table 111. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 112. BD Recent Developments
Table 113. Bio-Rad Laboratories Company Details
Table 114. Bio-Rad Laboratories Business Overview
Table 115. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product
Table 116. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 117. Bio-Rad Laboratories Recent Developments
Table 118. Cavidi Company Details
Table 119. Cavidi Business Overview
Table 120. Cavidi Infectious Disease Point of Care Diagnostics Product
Table 121. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 122. Cavidi Recent Developments
Table 123. Cepheid Company Details
Table 124. Cepheid Business Overview
Table 125. Cepheid Infectious Disease Point of Care Diagnostics Product
Table 126. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 127. Cepheid Recent Developments
Table 128. Diaxonhit Company Details
Table 129. Diaxonhit Business Overview
Table 130. Diaxonhit Infectious Disease Point of Care Diagnostics Product
Table 131. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 132. Diaxonhit Recent Developments
Table 133. Eiken Chemical Company Details
Table 134. Eiken Chemical Business Overview
Table 135. Eiken Chemical Infectious Disease Point of Care Diagnostics Product
Table 136. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 137. Eiken Chemical Recent Developments
Table 138. EMD Millipore Company Details
Table 139. EMD Millipore Business Overview
Table 140. EMD Millipore Infectious Disease Point of Care Diagnostics Product
Table 141. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 142. EMD Millipore Recent Developments
Table 143. Epitope Diagnostic Company Details
Table 144. Epitope Diagnostic Business Overview
Table 145. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product
Table 146. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 147. Epitope Diagnostic Recent Developments
Table 148. Euroimmun Company Details
Table 149. Euroimmun Business Overview
Table 150. Euroimmun Infectious Disease Point of Care Diagnostics Product
Table 151. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 152. Euroimmun Recent Developments
Table 153. Gold Standard Diagnostics Company Details
Table 154. Gold Standard Diagnostics Business Overview
Table 155. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product
Table 156. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 157. Gold Standard Diagnostics Recent Developments
Table 158. Hologic Company Details
Table 159. Hologic Business Overview
Table 160. Hologic Infectious Disease Point of Care Diagnostics Product
Table 161. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 162. Hologic Recent Developments
Table 163. Immunetics Company Details
Table 164. Immunetics Business Overview
Table 165. Immunetics Infectious Disease Point of Care Diagnostics Product
Table 166. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 167. Immunetics Recent Developments
Table 168. InBios International Company Details
Table 169. InBios International Business Overview
Table 170. InBios International Infectious Disease Point of Care Diagnostics Product
Table 171. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2019-2024) & (US$ Million)
Table 172. InBios International Recent Developments
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Over-the-counter (OTC) Testing Kits Features
Figure 4. Prescription-based Testing Kits Features
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Bacterial Infections Case Studies
Figure 8. Fungal Infection Case Studies
Figure 9. Virus Infection Case Studies
Figure 10. Cardiovascular Infection Case Studies
Figure 11. Gastrointestinal Infection Case Studies
Figure 12. Sexually Transmitted Disease (STD) Infection Case Studies
Figure 13. Central Nervous System Infection Case Studies
Figure 14. Other Case Studies
Figure 15. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 16. Global Infectious Disease Point of Care Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Infectious Disease Point of Care Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Region: 2023 VS 2030
Figure 19. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2023
Figure 20. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2023
Figure 22. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
Figure 24. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
Figure 25. North America Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
Figure 26. United States Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Infectious Disease Point of Care Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 29. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
Figure 30. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
Figure 31. Europe Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
Figure 32. Germany Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. China Infectious Disease Point of Care Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 39. China Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
Figure 40. China Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
Figure 41. Asia Infectious Disease Point of Care Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 42. Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
Figure 43. Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
Figure 44. Asia Infectious Disease Point of Care Diagnostics Market Share by Region (2019-2030)
Figure 45. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. South Korea Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Taiwan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Australia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Share by Type (2019-2030)
Figure 53. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2030)
Figure 54. Middle East, Africa, and Latin America Infectious Disease Point of Care Diagnostics Market Share by Country (2019-2030)
Figure 55. Brazil Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Mexico Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Turkey Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Israel Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GCC Countries Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 62. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 63. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 64. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 65. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 66. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 67. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 68. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 69. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 70. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 72. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 73. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 74. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 75. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 76. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 77. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 78. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 79. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 80. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 81. Immunetics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 82. InBios International Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2019-2024)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit